Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Open Label, Non Comparative, 24-week Study to Evaluate the Blood Glucose Lowering Efficacy and Safety of a Fixed Dose Combination of Glimepiride and Metformin in Patients With Inadequately Controlled Type 2 Diabetes

NCT01699932 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01699932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01699932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Open Label, Non Comparative, 24-week Study to Evaluate the Blood Glucose Lowering Efficacy and Safety of a Fixed Dose Combination of Glimepiride and Metformin in Patients With Inadequately Controlled Type 2 Diabetes
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2012
Completion date
April 30, 2014
Enrollment
167 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus